Abstract：Objective: To investigate the clinical characteristics and pathological features of small cell neuroendocrine carcinoma of the bladder (SCNECB) in order to improve the level of diagnosis and treatment. Methods: The diagnosis, treatment and patholoigical characteristics of one case of female SCNECB were introduced. Histological orgin, pathologic and immunohistochemical features, and diagnosis, treatment and prognosis of the tumor were analyzed with literature review. Results: The patient was subjected to transurethral resection of bladder tumor. The SCNECB was pathologically diagnosed. Immunohistochemically examination showed that the tumor was positive for neuroendocrine makers such as CK, TTF-1, NSE, CD56 and Syn. Conclusions: SCNEC is a rare and high malignant bladder cancer with specific pathological characteristics in urinary tract tumor. The tumor has a very poor prognosis. Radical surgery combined with chemotherapy or radiotherapy is the best treatment plan.
李高飞,张慕淳,张刚. 膀胱神经内分泌癌1例报道并文献复习[J]. 微创泌尿外科杂志, 2016, 5(1): 40-43.
Li Gaofei, Zhang Muchun, Zhang Gang,. Small cell neuroendocrine carcinoma of the bladder: one case report and review of the literature. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2016, 5(1): 40-43.
[1]Trias I, Algaba F, Condom E, et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol, 2001,39(1):85-90. [2]Ahsaini M, Riyach O, Tazi MF, et al. Small cell neuroendocrine carcinoma of the urinary tract successfully managed with neoadjuvant chemotherapy. Case Rep Urol, 2013:598325. [3]Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer, 2004, 101(5):957-962. [4]Nabi G, Singh I, Ansari MS, et al. Primary small cell neuroendocrine carcinoma of urinary bladder: all uncommon entity to be recognized. Int Urol Nephrol, 2001, 33(4):637-640. [5]Singh N, Khurana N, Singh M, et al. Primary mixed small cell neuroendocrine-adenocarcinoma of the urinary bladder. J Cancer Res Ther, 2011,7(4):493-496. [6]Cerulli C, Bustetto GM, Antonini G, et al. Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review. Urol Int, 2012, 88(3):365-369. [7]孙星慧,郑凯,吴卫真,等.膀胱小细胞神经内分泌癌1例报告并文献复习.临床泌尿外科杂志,2011,26(9):691-693. [8]Grignon DJ, Ro JY, Ayala AG, et al. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer, 1992,69(2):527-536. [9]Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer, 2005,103(6):1172-1178. [10]Lamberts SW, Hofland LJ, Nobels FR. Neuroendocrine tumor markers. Front Neuroendocrinol, 2001,22(4):309-339. [11]Helpap B. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract. Cancer, 2002,95(7):1415-1420. [12]Schreiber D, Rineer J, Weiss J, et al. Characterization and outcome of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database. Am J Clin Oncol, 2012,36(2):126-131. [13]Nejat RJ, Ravjeer P, Erik TG, et al. Cure of undifferentiated small cell carcinoma of the urinary bladder with M-VAC chemotherapy. Urol Oncol, 2001,6(2):53-55. [14]宋毅,席志军,孔祥田,等. 膀胱小细胞癌(附五例报告). 中华泌尿外科杂志,2001,22(4):214-216. [15]Abbas F, Civantos F, Benedetto P, et al. Small cell carcinoma of the bladder and prostate. Urology, 1995,46(5):617-630.
